BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20147982)

  • 1. Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risks.
    McMenamin MM; Wood MJ
    Gene Ther; 2010 Apr; 17(4):448-58. PubMed ID: 20147982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer therapy for neurodegenerative disorders.
    Feigin A; Eidelberg D
    Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of herpes simplex virus-based vectors for gene delivery to the nervous system.
    Lachmann RH; Efstathiou S
    Mol Med Today; 1997 Sep; 3(9):404-11. PubMed ID: 9302691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders.
    Terzi D; Zachariou V
    Biotechnol J; 2008 Dec; 3(12):1555-63. PubMed ID: 19072910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapeutic strategies for neurodegenerative diseases.
    Baekelandt V; De Strooper B; Nuttin B; Debyser Z
    Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral vectors as tools to model and treat neurodegenerative disorders.
    Déglon N; Hantraye P
    J Gene Med; 2005 May; 7(5):530-9. PubMed ID: 15651039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral vectors for the treatment of neurodegenerative diseases.
    Martin-Rendon E; Azzouz M; Mazarakis ND
    Curr Opin Mol Ther; 2001 Oct; 3(5):476-81. PubMed ID: 11699892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference based gene therapy for neurological disease.
    Jagannath A; Wood M
    Brief Funct Genomic Proteomic; 2007 Mar; 6(1):40-9. PubMed ID: 17478451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
    Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
    Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of viral vectors for neurological gene therapies.
    Maguire-Zeiss KA; Federoff HJ
    Curr Opin Mol Ther; 2004 Oct; 6(5):473-81. PubMed ID: 15537048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
    Nanou A; Azzouz M
    Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances, prospects and problems in designing new strategies for oligonucleotide and gene delivery in therapy.
    Romano G; Claudio PP; Kaiser HE; Giordano A
    In Vivo; 1998; 12(1):59-67. PubMed ID: 9575427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased in vitro and in vivo transgene expression levels mediated through cis-acting elements.
    Johansen J; Tornøe J; Møller A; Johansen TE
    J Gene Med; 2003 Dec; 5(12):1080-9. PubMed ID: 14661183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy in the CNS.
    Costantini LC; Bakowska JC; Breakefield XO; Isacson O
    Gene Ther; 2000 Jan; 7(2):93-109. PubMed ID: 10673714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immune response induced by gene delivery vectors.
    Sakurai H; Kawabata K; Sakurai F; Nakagawa S; Mizuguchi H
    Int J Pharm; 2008 Apr; 354(1-2):9-15. PubMed ID: 17640834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond small molecule drugs for heart failure: prospects for gene therapy.
    Chien KR
    Novartis Found Symp; 2006; 274():244-56; discussion 256-9, 272-6. PubMed ID: 17019816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV vectors: is clinical success on the horizon?
    Monahan PE; Samulski RJ
    Gene Ther; 2000 Jan; 7(1):24-30. PubMed ID: 10680012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects of treating neurological diseases by gene therapy.
    Lundstrom K
    Curr Opin Investig Drugs; 2007 Jan; 8(1):34-40. PubMed ID: 17263183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy progress and prospects: cystic fibrosis.
    Griesenbach U; Geddes DM; Alton EW
    Gene Ther; 2006 Jul; 13(14):1061-7. PubMed ID: 16819538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.